Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes

被引:22
作者
Bocci, Velio [1 ]
Zanardi, Iacopo [2 ]
Michaeli, David [3 ,4 ]
Travagli, Valter [2 ]
机构
[1] Univ Siena, Dept Physiol, Via Aldo Moro 2, I-53100 Siena, Italy
[2] Univ Siena, Dept Pharmaceut Chem & Technol, Siena, Italy
[3] Tel Aviv Univ, Med Sch, Rabin Med Ctr, Dept Neurosurg, Tel Aviv, Israel
[4] Microdel Idea Ctr LTD, Tel Aviv, Israel
关键词
Ozonetherapy; oxidative stress; antioxidants; ozone tolerance; hormesis; vascular diseases;
D O I
10.2174/157488509789055045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
After a long initial stage obscured by empirism and misconceptions, oxygen-ozonetherapy has now become a scientific discipline where the reactions between ozone and human blood are within the realm of orthodox biochemistry, physiology and pharmacology. Most of the basic mechanisms of action have been clarified and ozone can be considered a pro-drug, which almost instantaneously reacts with antioxidants and unsaturated fatty acids. These reactions generate the actual ozone messengers represented by either hydrogen peroxide as a fast acting compound or a variety of lipid oxidation products as late effectors. While ozone is totally consumed, micromolar amounts of these messengers are able to enhance the delivery of oxygen via erythrocyte activation, the immune system by a bland leukocyte stimulation and most of the remaining body cells by up-regulating the antioxidant system. The hazard of ozone toxicity has been dispelled by using the gas only within a dose range perfectly calibrated against the potent blood antioxidant capability. Ozonetherapy can be very useful in patients with chronic vascular disorders and ischemic problems and should be extensively used by official medicine. An extraordinary facet of ozone is its medical application versatility, as represented by several administration routes, and the minimal cost of this drug.
引用
收藏
页码:159 / 173
页数:15
相关论文
共 122 条
[1]  
Alary Jacques, 2003, Molecular Aspects of Medicine, V24, P177, DOI 10.1016/S0098-2997(03)00012-8
[2]   Albumin is the main nucleophilic target of human plasma: A protective role against pro-atherogenic electrophilic reactive carbonyl species? [J].
Aldini, Giancarlo ;
Vistoli, Giulio ;
Regazzoni, Luca ;
Gamberoni, Luca ;
Facino, Roberto Maffei ;
Yamaguchi, Satoru ;
Uchida, Koji ;
Carini, Marina .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (04) :824-835
[3]   Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal [J].
Aldini, Giancarlo ;
Gamberoni, Luca ;
Orioli, Marica ;
Beretta, Giangiacomo ;
Regazzoni, Luca ;
Facino, Roberto Maffei ;
Carini, Marina .
JOURNAL OF MASS SPECTROMETRY, 2006, 41 (09) :1149-1161
[4]  
Alexandre A, 2000, OZONOTERAPIA NEL 200, P141
[5]  
ALEXANDRE A, 2000, P 1 C IMOS IT SIEN 2, P7
[6]   Estimation of H2O2 gradients across biomembranes [J].
Antunes, F ;
Cadenas, E .
FEBS LETTERS, 2000, 475 (02) :121-126
[7]   Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferases [J].
Awasthi, YC ;
Ansari, GAS ;
Awasthi, S .
GLUTHIONE TRANSFERASES AND GAMMA-GLUTAMYL TRANSPEPTIDASES, 2005, 401 :379-407
[8]  
Ball P., 2001, NAT NEWS, DOI [10.1038/news011122-3, DOI 10.1038/NEWS011122-3]
[9]  
Barco G., 2007, INT J OZONE THER, V6, P157
[10]   The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products [J].
Barrera, Giuseppina ;
Toaldo, Cristina ;
Pizzimenti, Stefania ;
Cerbone, Angelo ;
Pettazzoni, Piergiorgio ;
Dianzani, Mario Umberto ;
Ferretti, Carlo .
PPAR RESEARCH, 2008, 2008